NIVOLUMAB Plus IPILIMUMAB and TEMOZOLOMIDE in Microsatellite Stable, MGMT Silenced Metastatic Colorectal Cancer
Clinical trial NCT03832621 · COMPLETED
Trial details
- NCT number
- NCT03832621
- Sponsor
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-25
- Primary completion
- 2021-09-30
- Enrollment
- 135
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.